A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder. [electronic resource]
Producer: 20130821Description: 313-21 p. digitalISSN:- 1469-5111
- Adolescent
- Adult
- Aged
- Antidepressive Agents -- therapeutic use
- Depressive Disorder, Major -- drug therapy
- Double-Blind Method
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Piperazines -- therapeutic use
- Psychiatric Status Rating Scales
- Sulfides -- therapeutic use
- United States
- Vortioxetine
- Young Adult
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.